North America
Imagene, Tempus AI to Collaborate on AI-Based Lung Cancer Diagnostics
Imagene's AI-based multigene panel for predicting non-small cell lung cancer biomarkers from biopsy images will be combined with Tempus' real-world data.
Labcorp Q4 Revenues Rise 10 Percent
Total revenues were $3.33 billion, up from $3.03 billion in the same quarter last year and slightly above the consensus Wall Street estimate of $3.31 billion.
Becton Dickinson to Spin Off Biosciences and Diagnostics Business as Q1 Revenues Grow 10 Percent
The separation is planned to be completed by the end of 2026 with the rest of the company transforming into a pure play medical technology player.
The company said that its molecular diagnostics revenues rose 7 percent on the strength of its women's health assays and Biotheranostics business.
GeneDx Shares Fall on Short Seller Report
Several Wall Street analysts took issue with the short seller's report, calling the claims false and unrelated to GeneDx's current operations.
Feb 3, 2025
360Dx Top 30 Rockets 10 Percent in January
Jan 31, 2025
US DOJ Resolves Two Lab Fraud Cases
Jan 31, 2025
Jan 30, 2025
Jan 30, 2025